Download Encite Receives the SureScripts White Coat of Quality

Encite Receives the SureScripts White Coat of Quality
Encite Inc., a leader in Healthcare Software Development specializing in Dermatology receives the
SureScripts White Coat of Quality.
09-May-2013 – Charlotte, NC - Encite Inc., a leader in Healthcare Software Development specializing
in Dermatology receives the SureScripts White Coat of Quality.
The SureScripts White Coat of Quality recognizes Encite as an e-Prescribing technology provider who
has demonstrated a commitment to the highest level of clinical quality. As a White Coat recipient, Encite
continues to improve prescription accuracy, completeness and safety. Encite as a company will continue
to strive to improve the e-prescribing process to ensure safe and effective medication therapy.
Encite's Electronic Prescription Writing is the most intuitive prescription writing module on the market
today. Because of its intuitive user interface and easy to follow work flow it requires little training and is
usable within a few moments. This affords healthcare professionals the ability to quickly and easily
transition to e-prescribing.
Encite utilizes SureScripts, the industry standard, to offer e-Prescribing to our dermatology practices.
Medications are sent electronically to pharmacies, providing tremendous efficiency reducing errors while
providing high levels of security in the process.
About Encite, Inc.
Encite Inc. is a privately held Healthcare Software Developer whose only business is the development
and implementation of EHR Dermatology specific software. Encite’s EHR achieves the highest level of
patient satisfaction while meeting the challenges of regulatory compliances. The company’s Dermatology
specific Electronic Health Records and Practice Management solution is proven for both large and small
medical practices. The company takes a unique approach to patient charting with the latest technologies
resulting in fast, efficient flexible charting. The company’s corporate headquarters is located in Charlotte,
North Carolina. For additional information please contact or visit Encite at www.encite.us.